Clinical outcomes of the AcrySof IQ Vivity DFT215 intraocular lens in patients with low corneal astigmatism after cataract surgery
- Conditions
- Eyes operated by cararact surgery
- Registration Number
- DRKS00030579
- Lead Sponsor
- Promoter's representative of OFTALVIST (Oftalmología Vistahermosa, SL)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 47
Inclusion Criteria
1. Patients undergoing cataract surgery and candidates for AcrySof IQ Vivity DFT215 IOL implantation.
2. Age between 55 and 85 years old.
3. Presence of low corneal astigmatism.
Exclusion Criteria
1. Dry eye or lacrimal alteration evaluated with the Keratograph 5M.
2. Glaucoma, corneal or retinal diseases.
3. Previous intraocular or corneal surgery.
4. Patients with missing information or missing data will be discarded from the analysis.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate uncorrected monocular distance visual acuity after AcrySof IQ Vivity DFT215 IOL implantation following cataract surgery. The study data will be obtained from the clinical history and tests performed on patients treated according to standard clinical practice.
- Secondary Outcome Measures
Name Time Method - Evaluation of refraction, <br>- evaluation of the patient's visual acuity at intermediate and near distance (with and without distance correction), <br>- evaluation of the defocus curve, <br>- evaluation of rotational stability <br>- and satisfaction evaluation.